BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12460870)

  • 1. Differentiation between obesity and insulin resistance in the association with C-reactive protein.
    McLaughlin T; Abbasi F; Lamendola C; Liang L; Reaven G; Schaaf P; Reaven P
    Circulation; 2002 Dec; 106(23):2908-12. PubMed ID: 12460870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women.
    Ryan AS; Nicklas BJ
    Diabetes Care; 2004 Jul; 27(7):1699-705. PubMed ID: 15220249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in C-reactive protein following weight loss in obese insulin resistant postmenopausal women: is there an independent contribution of lean body mass?
    Barsalani R; Riesco É; Perreault K; Imbeault P; Brochu M; Dionne IJ
    Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):198-203. PubMed ID: 25658658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.
    McLaughlin T; Stühlinger M; Lamendola C; Abbasi F; Bialek J; Reaven GM; Tsao PS
    J Clin Endocrinol Metab; 2006 May; 91(5):1896-900. PubMed ID: 16507636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women.
    Abbasi F; Lamendola C; McLaughlin T; Hayden J; Reaven GM; Reaven PD
    Metabolism; 2004 Mar; 53(3):280-3. PubMed ID: 15015137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors.
    Bougoulia M; Triantos A; Koliakos G
    Hormones (Athens); 2006; 5(3):192-9. PubMed ID: 16950753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glucose disposal after a caloric restriction-induced weight loss program in obese postmenopausal women: characteristics of positive and negative responders in a Montreal-Ottawa New Emerging Team study.
    Myette-Côté É; Doucet É; Prud'homme D; Rabasa-Lhoret R; Lavoie JM; Brochu M
    Menopause; 2015 Jan; 22(1):96-103. PubMed ID: 24977460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians.
    Forouhi NG; Sattar N; McKeigue PM
    Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1327-31. PubMed ID: 11571595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of improvement in insulin sensitivity following a dietary weight loss programme.
    McLaughlin T; Schweitzer P; Carter S; Yen CG; Lamendola C; Abbasi F; Reaven G
    Diabetes Obes Metab; 2008 Dec; 10(12):1186-94. PubMed ID: 18476986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress is associated with C-reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance.
    Park S; Kim M; Paik JK; Jang YJ; Lee SH; Lee JH
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):65-70. PubMed ID: 22816656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
    Wu DM; Chu NF; Shen MH; Wang SC
    Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity.
    Borges RL; Ribeiro-Filho FF; Carvalho KM; Zanella MT
    Arq Bras Cardiol; 2007 Dec; 89(6):409-14. PubMed ID: 18317625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a 12-month moderate weight loss intervention on insulin sensitivity and inflammation status in nondiabetic overweight and obese subjects.
    Ho TP; Zhao X; Courville AB; Linderman JD; Smith S; Sebring N; Della Valle DM; Fitzpatrick B; Simchowitz L; Celi FS
    Horm Metab Res; 2015 Apr; 47(4):289-96. PubMed ID: 24977656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.